Biotech

All Articles

Vertex, beaten by AATD once again, goes down 2 assets on dispose of heap

.Tip's effort to handle an uncommon hereditary health condition has actually attacked an additional ...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of team

.Vir Biotechnology's second-quarter profits document wasn't except big information. The business inv...

Galapagos stops CAR-T cell treatment litigation over Parkinsonism instance

.Galapagos has stopped briefly registration in a trial of a BCMA-directed CAR-T cell therapy, pumpin...

James Wilson leaving behind Penn to introduce pair of new biotechs

.After more than three decades, genetics treatment innovator James Wilson M.D., Ph.D., is leaving th...

3 biotechs make an effort to defeat the summertime warmth by dropping team

.As biotechs try to switch a new page in August, a minimum of 3 firms have actually shed workers in ...

venBio lifts $528M for fifth lifestyle scientific researches VC fund

.Expert venture capital organization venBio has lifted one more half a billion bucks to buy biotechs...

Otsuka pays $800M for Jnana and also its own clinical-stage PKU drug

.Otsuka Pharmaceutical has gotten Boston-based Jnana Rehabs for $800 thousand so the Oriental biotec...

FibroGen lays off 75% of US staff as resource fails 2 even more trials

.FibroGen is substantially reorganizing its own company, giving up 75% of its own united state worke...

Tracon relax full weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has chosen to wind down functions weeks after an injectable invulnerable che...

Ideaya bags option on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...